BRIEF published on 07/29/2025 at 12:05, 5 months 21 days ago K+S Aktiengesellschaft's Q2 2025 Results: EBITDA Below Expectations, FCF In Line EBITDA Free Cash Flow Q2 2025 Results Exchange Rate Impact K+S Financial Forecast
BRIEF published on 07/29/2025 at 12:05, 5 months 21 days ago Résultats du deuxième trimestre 2025 de K+S Aktiengesellschaft : EBITDA inférieur aux attentes, flux de trésorerie disponible conforme EBITDA Flux De Trésorerie Disponible Résultats Du Deuxième Trimestre 2025 Impact Du Taux De Change Prévisions Financières De K+S
BRIEF published on 07/29/2025 at 12:05, 5 months 21 days ago SMX Transforms Decarbonization with Verifiable Traceability Decarbonization Infrastructure Traceability SMX Green Methanol
BRIEF published on 07/29/2025 at 12:05, 5 months 21 days ago SMX transforme la décarbonation grâce à une traçabilité vérifiable Infrastructure Décarburation Traçabilité SMX Méthanol Vert
BRIEF published on 07/29/2025 at 11:59, 5 months 21 days ago Orange : Rapport financier du premier semestre 2025 Stratégie Telecommunications Rapport Financier Orange Premier Semestre 2025
BRIEF published on 07/29/2025 at 11:59, 5 months 21 days ago Orange: Financial report for the first half of 2025 Telecommunications Financial Report Strategy Orange First Half Of 2025
BRIEF published on 07/29/2025 at 11:05, 5 months 21 days ago DN Deutsche Nachhaltigkeit AG: Shift to Impact Investing Financial Performance Investment Strategy Impact Investing Technology Innovations Portfolio Realignment
BRIEF published on 07/29/2025 at 11:05, 5 months 21 days ago DN Deutsche Nachhaltigkeit AG : passage à l'investissement d'impact Performance Financière Stratégie D'investissement Investissement D'Impact Innovations Technologiques Réalignement Du Portefeuille
BRIEF published on 07/29/2025 at 11:05, 5 months 21 days ago Meliodays and Celanese Collaborate on Hormone-Free IUD for Menstrual Pain Hormone-Free IUD Menstrual Pain Relief Meliodays VitalDose Platform Celanese Partnership
BRIEF published on 07/29/2025 at 11:05, 5 months 21 days ago Meliodays et Celanese collaborent sur un stérilet sans hormones pour les douleurs menstruelles Meliodays DIU Sans Hormones Soulagement Des Douleurs Menstruelles Plateforme VitalDose Partenariat Celanese
Published on 01/20/2026 at 08:00, 8 minutes ago Grande Portage Resources Receives Approval for 2026 Plan of Operations (Drill Permit) from the US Forest Service
Published on 01/20/2026 at 01:10, 6 hours 58 minutes ago Kalo Gold Announces Closing of Second and Final Tranche of Life Offering and Concurrent Private Placement for Total Gross Proceeds of $12.45 Million to Advance the Vatu Aurum Project
Published on 01/20/2026 at 00:35, 7 hours 33 minutes ago Kidoz Welcomes France’s Proposed Under-15 Social Media Ban
Published on 01/20/2026 at 00:00, 8 hours 8 minutes ago RE Royalties Announces Annual Grant of Stock Options and Restricted Share Units
Published on 01/19/2026 at 22:55, 9 hours 13 minutes ago Organto Foods Inc. Implements Early Warrant Exercise Incentive Program
Published on 01/20/2026 at 07:45, 23 minutes ago Le projet de plan de continuation de REALITES obtient un très fort soutien de ses créanciers et actionnaires en vue de l’audience du 4 février 2026 au Tribunal de Commerce de Nantes
Published on 01/20/2026 at 07:35, 33 minutes ago Andera Partners’ Portfolio Company Exciva Secures €51 Million Series B to Advance Clinical Program for Alzheimer’s-Related Agitation
Published on 01/20/2026 at 07:30, 38 minutes ago Circus Defence Delivers AI Robots to the German Armed Forces
Published on 01/20/2026 at 07:30, 38 minutes ago Vienna Airport sets new passenger records in 2025 with 43.4 million (Flughafen Wien Group) and 32.6 million (Vienna) and record cargo volume
Published on 01/20/2026 at 07:10, 58 minutes ago Hypoport SE: Double-digit percentage growth in transaction volume in mortgages continues in 2025
Published on 01/20/2026 at 07:30, 38 minutes ago Gimv leidt een Series B investeringsronde van EUR 51 miljoen in Exciva voor verdere ontwikkeling van een innovatieve Alzheimerbehandeling
Published on 01/20/2026 at 07:30, 38 minutes ago Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy
Published on 01/20/2026 at 07:30, 38 minutes ago Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy
Published on 01/19/2026 at 17:45, 14 hours 23 minutes ago Calendrier de communication financière 2026
